Study Shows High Engagement With Digital Therapy for Schizophrenia Spectrum Disorders – Mobi Health News

Read article - Quotes Dror Ben-Zeev, assistant professor of psychiatry, about a study he led that shows promising engagement with Pear Therapeutics' program Thrive, which uses a smartphone app along with medication to treat patients with schizophrenia, schizoaffective disorder and bipolar disorder. "Patients with schizophrenia are traditionally considered a high risk patient population and the period immediately following hospitalization is of particularly high risk. This study debunks the concern that patients who are not clinically stable are not capable of using mobile interventions," says Ben-Zeev.